Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Feb 3;16(2):e53501.
doi: 10.7759/cureus.53501. eCollection 2024 Feb.

Cardiac Tamponade and Primary Biliary Cholangitis: An Unusual Presentation and a Rare Association of Systemic Lupus Erythematosus

Affiliations
Case Reports

Cardiac Tamponade and Primary Biliary Cholangitis: An Unusual Presentation and a Rare Association of Systemic Lupus Erythematosus

Ana Carvoeiro et al. Cureus. .

Abstract

Systemic lupus erythematosus (SLE) is a disease known for its multiple manifestations, including numerous cardiac complications. While pericardial effusions are common in patients with SLE, cardiac tamponade is rare, and it is even rarer as an initial and isolated clinical manifestation of SLE. We describe a case of a young adult woman who presented with a four-week history of shortness of breath, orthopnea, and paroxysmal nocturnal dyspnea. Chest radiography revealed a significant increase in the cardiothoracic index, and transthoracic echocardiography confirmed a life-threatening cardiac tamponade that necessitated emergency pericardiocentesis and high-dose corticosteroids. Following a thorough investigation, we excluded viral infection, malignancy, tuberculosis, and other autoimmune diseases, and the patient was diagnosed with SLE based on the Systemic Lupus International Collaborating Clinics (SLICC) criteria. In this case report, we also present an uncommon association between SLE and primary biliary cholangitis (PBC). While both are autoimmune diseases, the coexistence of these two conditions in the same patient is rare. The report highlights the need for ongoing research to better understand the optimal management strategies for patients with coexisting autoimmune conditions.

Keywords: cardiac tamponade; pericardial effusions; primary biliary cholangitis; rare autoimmune disease; systemic lupus erythematosus.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Electrocardiogram on admission revealing sinus bradycardia, low voltage, and electrical alternans
Figure 2
Figure 2. Chest radiography (posteroanterior view) at admission revealing enlarged cardiac silhouette and a small volume left pleural effusion
Figure 3
Figure 3. Thoracoabdominopelvic scan after pericardiocentesis showing moderate pericardial effusion (arrow)
Figure 4
Figure 4. Echocardiogram (parasternal long-axis view) after pericardiocentesis demonstrating residual pericardial effusion of moderate volume
PE: pericardial effusion; LA: left atrium; LV: left ventricle; Ao: aortic valve; RV: right ventricle
Figure 5
Figure 5. Follow-up chest radiography (A) and echocardiogram (B) revealing minor pericardial effusion
PE: pericardial effusion; LA: left atrium; LV: left ventricle; Ao: aortic valve; RV: right ventricle

Similar articles

References

    1. Cardiovascular manifestations of systemic lupus erythematosus. Doherty NE, Siegel RJ. Am Heart J. 1985;110:1257–1265. - PubMed
    1. Cardiovascular involvement in systemic lupus erythematosus. Mandell B. Semin Arthritis Rheum. 1987;17:126–141. - PubMed
    1. The spectrum of clinical manifestations, outcome and treatment of pericardial tamponade in patients with systemic lupus erythematosus: a retrospective study and literature review. Rosenbaum E, Krebs E, Cohen M, Tiliakos A, Derk CT. Lupus. 2009;18:608–612. - PubMed
    1. A case of primary biliary cirrhosis which developed eight years after diagnosis of systemic lupus erythematosus. Shizuma T, Kuroda H. Intern Med. 2011;50:321–324. - PubMed
    1. Implications of genome-wide association studies in novel therapeutics in primary biliary cirrhosis. Carbone M, Lleo A, Sandford RN, Invernizzi P. Eur J Immunol. 2014;44:945–954. - PMC - PubMed

Publication types

LinkOut - more resources